INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 48m ago
House PTR7m ago
SEC 13F7m ago
Robinhood Chain7m ago

Results

6,734 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
SJ
Springer JonDirector
UVEUNIVERSAL INSURANCE HOLDINGS, INC.
Open-market sale
SELL$1.22M
25.0K sh
Nov 3, 2026Nov 5, 2026
Page 8 of 169
← PrevNext →
traded Nov 3, 2026
+2d
SEC Form 4

Evidence

34
GM
Giglietti Robert M.Vice President
GEGENERAL ELECTRIC CO
Open-market sale
SELL$3.66M
11.0K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

34
HT
Hill J ThomasDirector
VMCVulcan Materials CO
Open-market sale
SELL$2.22M
7,768 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

34
BE
Bruni EnricoMD, Co-Head of Global Markets
TWTradeweb Markets Inc.
Open-market sale
SELL$1.58M
12.6K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

34
SM
Schuessler Morgan MDirector, President & CEO
EVTCEVERTEC, Inc.
Open-market sale
SELL$2.11M
59.9K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

34
SM
Schuessler Morgan MDirector, President & CEO
EVTCEVERTEC, Inc.
Open-market sale
SELL$2.94M
85.1K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

34
HT
Hill J ThomasDirector
VMCVulcan Materials CO
Open-market sale
SELL$1.74M
6,082 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

34
HT
Hill J ThomasDirector
VMCVulcan Materials CO
Open-market sale
SELL$3.27M
11.5K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

34
BH
Barratt Craig HDirector
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$529K
1,150 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

34
PJ
Platt Ira J.Director
CVNACARVANA CO.
Open-market sale
SELL$1.11M
15.0K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

34
PJ
Platt Ira J.Director
CVNACARVANA CO.
Open-market sale
SELL$1.13M
14.6K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

33
HD
Hill Jonathan D.Chief Financial Officer
PKBKPARKE BANCORP, INC.
Open-market sale
SELL$15K
454 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

33
PA
Paganelli John ADirector
OPKOPKO HEALTH, INC.
Open-market sale
SELL$17K
9,175 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC Form 4

Evidence

33
GH
Genworth Holdings, Inc.10% Owner
ACTEnact Holdings, Inc.
Open-market sale
SELL$45.19M
990.6K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

32
BM
Bystrom MattiasSVP, PQI
VLTOVeralto Corp
Open-market sale
SELL$40K
346 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

32
BD
Berho Carranza DiegoChief Portfolio Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$131K
35.0K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

32
EA
Egawa AtsushiCo-CEO Asia Pacific
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$2.70M
10.0K sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC Form 4

Evidence

32
BM
Bystrom MattiasSVP, PQI
VLTOVeralto Corp
Open-market sale
SELL$14K
124 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
HT
Hill J ThomasDirector
VMCVulcan Materials CO
Open-market sale
SELL$764K
2,660 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
RM
Reaume Marty MDirector
SPSCSPS COMMERCE INC
Open-market sale
SELL$394K
4,536 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
CJ
Cappello JosephChief Technical Officer
GNLXGENELUX Corp
Open-market sale
SELL$1,363
668 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
BE
Bruni EnricoMD, Co-Head of Global Markets
TWTradeweb Markets Inc.
Open-market sale
SELL$753K
5,937 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
YY
Yu YongChief Scientific Officer
GNLXGENELUX Corp
Open-market sale
SELL$1,344
668 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
KH
Kliman Gilbert HDirector
GKOSGLAUKOS Corp
Open-market sale
SELL$633K
2,500 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

31
ZT
Zindrick ThomasPresident and CEO
GNLXGENELUX Corp
Open-market sale
SELL$6,317
3,089 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
GP
Gale Mary PorterDirector
RDDTReddit, Inc.
Open-market sale
SELL$288K
3,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

31
RN
Reddy NeenaGeneral Counsel and Secretary
OWLBLUE OWL CAPITAL INC.
Open-market sale
SELL$419K
40.3K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

30
GM
Giglietti Robert M.Vice President
GEGENERAL ELECTRIC CO
Open-market sale
SELL$1.26M
3,780 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

30
MJ
Mcnamara Kevin JDirector, president and CEO
CHECHEMED CORP
Open-market sale
SELL$1.08M
2,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

30
WM
Whalen Chad MichaelEVP, Worldwide Sales
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$646K
1,960 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

30
WM
Whalen Chad MichaelEVP, Worldwide Sales
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$995K
3,009 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

30
OM
Okeke Angelique MEVP, General Counsel
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$326K
1,007 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

53
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$6.83M
7,073 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
WL
Way T LawrenceDirector
CUBICustomers Bancorp, Inc.
Open-market sale
SELL$4.09M
48.8K sh
Oct 30, 2026Nov 4, 2026
traded Oct 30, 2026
+5dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$4.18M
4,338 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.47M
1,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$3.80M
3,939 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.58M
2,670 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.43M
2,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
GL
Garceau Mary LSVP - CLO and Secretary
SHWSHERWIN WILLIAMS CO
Open-market sale
SELL$1.36M
3,891 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence